Olanzapine depot for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 8 JUL 2009
Assessed as up-to-date: 29 MAR 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Herath Mudiyanselage I, Alagarsamy J, Kachhap S, Jayaram MB. Olanzapine depot for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007947. DOI: 10.1002/14651858.CD007947.
- Publication Status: New
- Published Online: 8 JUL 2009
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effectiveness of olanzapine LAI (long-acting Injection) in comparison with placebo, oral antipsychotics and other depot antipsychotic preparations for people with schizophrenia and other severe mental illnesses.